Evaluation of Potentially Predictive Markers for Anti-Angiogenic Therapy with Sunitinib in Recurrent Ovarian Cancer Patients

INTRODUCTION: In ovarian cancer, new therapeutic strategies are needed because the vast majority of patients develop a recurrence and resistance to platinum derivates. Attached to the AGO-OVAR2.11 study investigating the multityrosine kinase inhibitor sunitinib in recurrent platinum refractory ovari...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bauerschlag, Dirk O, Hilpert, Felix, Meier, Werner, Rau, Jörn, Meinhold-Heerlein, Ivo, Maass, Nicolai, duBois, Andreas, Sehouli, Jalid, Arnold, Norbert, Schem, Christian, Oberg, Hans-Heinrich, Baumann, Klaus
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press Inc. 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3660799/
https://ncbi.nlm.nih.gov/pubmed/23730410
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak